Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bruker (BRKR) Acquisitions (2016 - 2025)

Bruker (BRKR) has disclosed Acquisitions for 14 consecutive years, with $4.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Acquisitions fell 81.66% year-over-year to $4.2 million, compared with a TTM value of $73.9 million through Dec 2025, down 95.38%, and an annual FY2025 reading of $73.9 million, down 95.38% over the prior year.
  • Acquisitions was $4.2 million for Q4 2025 at Bruker, up from $200000.0 in the prior quarter.
  • Across five years, Acquisitions topped out at $1.3 billion in Q2 2024 and bottomed at $100000.0 in Q3 2022.
  • Average Acquisitions over 5 years is $113.0 million, with a median of $20.0 million recorded in 2021.
  • The sharpest move saw Acquisitions skyrocketed 119500.0% in 2023, then tumbled 99.83% in 2024.
  • Year by year, Acquisitions stood at $20.0 million in 2021, then soared by 384.0% to $96.8 million in 2022, then crashed by 95.56% to $4.3 million in 2023, then skyrocketed by 432.56% to $22.9 million in 2024, then plummeted by 81.66% to $4.2 million in 2025.
  • Business Quant data shows Acquisitions for BRKR at $4.2 million in Q4 2025, $200000.0 in Q3 2025, and $68.4 million in Q2 2025.